June 15, 2018 — Deborah Gold, Chief Executive of NAT (National AIDS Trust) said: “This proposed trial expansion, from 10,000 to 13,000 participants, is essential and we urge NHS England to confirm the decision urgently. This expansion was first proposed by NAT as necessary to estimate accurately the likely long-term needs of a routinely commissioned PrEP programme and it’s great news that this is now on the table.
“But even an expanded trial will not deliver PrEP to all who need and want it over the trial’s three-year duration. And we cannot accept a situation where people who are eligible for PrEP and who are desperate to take responsibility for preventing HIV are being turned away from clinics that are full.
“We now need to see real, transparent progress towards routine commissioning of a PrEP national programme. We must ensure that no one who needs to access PrEP is refused.”
NAT (National AIDS Trust) is the UK’s leading charity dedicated to transforming society’s response to HIV. We provide fresh thinking, expertise and practical resources. We champion the rights of people living with HIV and campaign for change.
Shaping attitudes. Challenging injustice. Changing lives.